Citation Impact
Citing Papers
Enterococcus faecalis Infective Endocarditis
2013
Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations
2010
Surface Charge-Switching Polymeric Nanoparticles for Bacterial Cell Wall-Targeted Delivery of Antibiotics
2012
Linezolid Alone or Combined with Rifampin against Methicillin-Resistant Staphylococcus aureus in Experimental Foreign-Body Infection
2008
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Infective Endocarditis
2005 Standout
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
2012
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
No health without mental health
2007 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues
2007
Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice
2011 StandoutNobel
Prosthetic-Joint Infections
2004 Standout
Hypoxia and Inflammation
2011 Standout
Antibiotic resistance of bacteria in biofilms
2001 Standout
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 Standout
Regulation of hypoxia adaptation: an overlooked virulence attribute of pathogenic fungi?
2010
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci
1999
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
Nonresolving Inflammation
2010 Standout
The Science of Antibiotic Discovery
2020 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Programmes and principles in treatment of multidrug-resistant tuberculosis
2004
Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems
2005
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
2013 StandoutNobel
Intravascular-catheter-related infections
1998
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Role of Rifampin for Treatment of Orthopedic Implant–Related Staphylococcal Infections <SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1998
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
2005
Vertebral Osteomyelitis
2010 Standout
Prevention of sepsis in total joint arthroplasty
1996
Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent Manner
2008 StandoutNobel
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Helicobacter pyloriInfection
2002 Standout
Self-Organization, Layered Structure, and Aggregation Enhance Persistence of a Synthetic Biofilm Consortium
2011 StandoutNobel
Reducing implant-related infections: active release strategies
2006 Standout
Prosthetic Joint Infections
2005
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Activated ClpP kills persisters and eradicates a chronic biofilm infection
2013 Nature
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Infective endocarditis
2004 Standout
Computational design of ligand-binding proteins with high affinity and selectivity
2013 StandoutNatureNobel
Treatment of Infections Associated with Surgical Implants
2004 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections
2008
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
2003 StandoutNature
The population dynamics of antimicrobial chemotherapy
1997
Campylobacter pyloridis, gastritis, and peptic ulceration.
1986
Impact of High-InoculumStaphylococcus aureuson the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model
2004
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Bacterial and Fungal Biofilm Infections
2007
Quinupristin-Dalfopristin Combined with β-Lactams for Treatment of Experimental Endocarditis Due to Staphylococcus aureus Constitutively Resistant to Macrolide-Lincosamide-Streptogramin B Antibiotics
2000
Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
2009
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics
1997
BactericidalActivities of Daptomycin, Quinupristin-Dalfopristin, and Linezolidagainst Vancomycin-ResistantStaphylococcus aureusinan In Vitro Pharmacodynamic Model with SimulatedEndocardialVegetations
2003
Preventing Complications of Central Venous Catheterization
2003 Standout
Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections
1991
Ligand-Binding Proteins: Their Potential for Application in Systems for Controlled Delivery and Uptake of Ligands
2000
Normoxic Stabilization of Hypoxia-Inducible Factor-1α by Modulation of the Labile Iron Pool in Differentiating U937 Macrophages: Effect of Natural Resistance–Associated Macrophage Protein 1
2006 StandoutNobel
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
1995
Bacterial Biofilms: A Common Cause of Persistent Infections
1999 StandoutScience
Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
2009
Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus
1994
BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis
2002
Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
2011
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Impact of Bacterial Biofilm Formation on In Vitro and In Vivo Activities of Antibiotics
1998
Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria
1999
Role of Antibiotic Penetration Limitation in Klebsiella pneumoniae Biofilm Resistance to Ampicillin and Ciprofloxacin
2000
Short-Course Gentamicin in Combination with Daptomycin or Vancomycin against Staphylococcus aureus in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations
2005
Polyoxometalates in Medicine
1998 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations
2008
Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF‐2 pathway
2015 StandoutNobel
Lipopolysaccharide Endotoxins
2002 Standout
Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease
1996
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
Biofilm Formation as Microbial Development
2000 Standout
Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections
2005
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500
1995
Treatment of Vancomycin-Resistant Enterococcus faecium with RP 59500 (Quinupristin-Dalfopristin) Administered by Intermittent or Continuous Infusion, Alone or in Combination with Doxycycline, in an In Vitro Pharmacodynamic Infection Model with Simulated Endocardial Vegetations
1998
Works of J. Blaser being referenced
Role of Amoxicillin Serum Levels for Successful Prophylaxis of Experimental Endocarditis Due to Tolerant Streptococci
1994
Amikacin, Ceftazidime, and Flucloxacillin against Suspended and Adherent Pseudomonas aeruginosa and Staphylococcus epidermidis in an In Vitro Model of Infection
1992
Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro
1993
Multicenter Quality Control Study of Amikacin Assay for Monitoring Once-Daily Dosing Regimens
1995
In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods
1986
Two compartment kinetic model with multiple artificial capillary units
1985
Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats
1994
In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives
1985
Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance
1987
Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model
1996
Significance of "extravascular" protein binding for antimicrobial pharmacodynamics in an in vitro capillary model of infection
1990
Analysis of pH, pO2 and pCO2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery
1994
In vivo verification of in vitro model of antibiotic treatment of device-related infection
1995